Bart Kus

791 total citations
9 papers, 652 citations indexed

About

Bart Kus is a scholar working on Molecular Biology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bart Kus has authored 9 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Physiology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bart Kus's work include Ubiquitin and proteasome pathways (4 papers), Computational Drug Discovery Methods (2 papers) and Cystic Fibrosis Research Advances (2 papers). Bart Kus is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Computational Drug Discovery Methods (2 papers) and Cystic Fibrosis Research Advances (2 papers). Bart Kus collaborates with scholars based in Canada, United States and Netherlands. Bart Kus's co-authors include A.M. Edwards, Ronald Jansen, Dov Greenbaum, Jack Greenblatt, Mark Gerstein, Daniela Rotin, Catherine E Caldon, John Parkinson, Nevan J. Krogan and James D. Wasmuth and has published in prestigious journals such as Journal of Biological Chemistry, Trends in Genetics and Molecular Pharmacology.

In The Last Decade

Bart Kus

9 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bart Kus Canada 8 522 114 99 48 48 9 652
Heejun Hwang South Korea 7 462 0.9× 57 0.5× 56 0.6× 48 1.0× 42 0.9× 9 649
Rudolf Pillich United States 13 501 1.0× 143 1.3× 24 0.2× 40 0.8× 46 1.0× 21 711
Irene de Miguel Spain 16 368 0.7× 59 0.5× 36 0.4× 66 1.4× 22 0.5× 28 651
Karen Rothfels Canada 4 256 0.5× 46 0.4× 26 0.3× 25 0.5× 27 0.6× 9 407
Yu-Yi Lin Taiwan 10 625 1.2× 62 0.5× 36 0.4× 54 1.1× 21 0.4× 18 966
Marina Bessarabova United States 11 491 0.9× 30 0.3× 28 0.3× 75 1.6× 164 3.4× 13 697
Chamila N. Rupasinghe United States 13 321 0.6× 99 0.9× 27 0.3× 40 0.8× 26 0.5× 18 464
Lorena A. Kallal United States 13 732 1.4× 115 1.0× 12 0.1× 56 1.2× 58 1.2× 25 895
Kazuhisa Ota Japan 14 657 1.3× 157 1.4× 19 0.2× 79 1.6× 15 0.3× 21 805
Ruth V. Spriggs United Kingdom 16 818 1.6× 32 0.3× 22 0.2× 37 0.8× 50 1.0× 29 987

Countries citing papers authored by Bart Kus

Since Specialization
Citations

This map shows the geographic impact of Bart Kus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Kus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Kus more than expected).

Fields of papers citing papers by Bart Kus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Kus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Kus. The network helps show where Bart Kus may publish in the future.

Co-authorship network of co-authors of Bart Kus

This figure shows the co-authorship network connecting the top 25 collaborators of Bart Kus. A scholar is included among the top collaborators of Bart Kus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart Kus. Bart Kus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Carlile, Graeme W., Renaud Robert, Julie Goepp, et al.. (2014). Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking. Journal of Cystic Fibrosis. 14(1). 16–25. 38 indexed citations
2.
Robert, Renaud, Graeme W. Carlile, Jie Liao, et al.. (2010). Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine. Molecular Pharmacology. 77(6). 922–930. 80 indexed citations
3.
Scrocchi, Louise A., Elizabeth Karaskov, Vivian Lee, et al.. (2010). P1‐174: Early detection of β‐amyloid aggregation in in vivo and in vitro models of Alzheimer's disease. Alzheimer s & Dementia. 6(4S_Part_7). 1 indexed citations
4.
Kus, Bart, James D. Wasmuth, Raffi Tonikian, et al.. (2007). Ubiquitination screen using protein microarrays for comprehensive identification of Rsp5 substrates in yeast. Molecular Systems Biology. 3(1). 116–116. 131 indexed citations
5.
Kus, Bart, Aaron S. Gajadhar, Karen Stanger, et al.. (2005). A High Throughput Screen to Identify Substrates for the Ubiquitin Ligase Rsp5. Journal of Biological Chemistry. 280(33). 29470–29478. 35 indexed citations
6.
Gwizdek, Carole, Maria Hobeika, Bart Kus, et al.. (2005). The mRNA Nuclear Export Factor Hpr1 Is Regulated by Rsp5-mediated Ubiquitylation. Journal of Biological Chemistry. 280(14). 13401–13405. 61 indexed citations
7.
Kus, Bart, et al.. (2003). Functional interaction of 13 yeast SCF complexes with a set of yeast E2 enzymes in vitro. Proteins Structure Function and Bioinformatics. 54(3). 455–467. 64 indexed citations
8.
Edwards, A.M., Bart Kus, Ronald Jansen, et al.. (2002). Bridging structural biology and genomics: assessing protein interaction data with known complexes. Trends in Genetics. 18(10). 529–536. 204 indexed citations
9.
Thavendiranathan, Paaladinesh, et al.. (1999). Neuroprotective effects of acetylsalicylic acid in an animal model of focal brain ischemia. Neuroreport. 10(2). 371–374. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026